Newsfiscal.ai
Lexaria Bioscience Reaches Full Enrollment for GLP-1 Human Pilot Study #7
· Published
Article summary
Lexaria Bioscience Corp. has achieved full enrollment and continues dosing for its Human Pilot Study #7, which evaluates oral DehydraTECH-semaglutide compositions.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…